Source link : https://www.newshealth.biz/health-news/fda-approves-novel-treatment-for-utis/
The FDA approved oral sulopenem etzadroxil and probenecid (Orlynvah) to treat uncomplicated urinary tract infections (uUTIs) caused by certain bacteria in women with limited or no alternative oral antibacterial treatment options, the agency said Friday. The drug is a combination of a penem antibacterial (sulopenem etzadroxil) and a renal tubular transport inhibitor (probenecid). It is […]
Author : News Health
Publish date : 2024-10-25 20:47:02
Copyright for syndicated content belongs to the linked Source.